Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug Trials
Non-publication of trial results has been a major concern in clinical research since a couple of decades. The …
In this briefing paper Dr Maura Hiney, Chair of the Science Europe Working Group on Research Integrity, gives a clear and well structured overview of the evidence and developments in the field of research integrity and research misconduct. It captures and analyses all the relevant stakeholders and actors, and Hiney raises interesting questions about individual and collective responsibility.
Relevant for all who wants to learn more about the history of research integrity –for example on the role of the mass-media in putting the topic high on the public agenda- and where we are at now. Food for thought and easy to read!
Title: Research Integrity: what it means, why it is important and how we might protect it
Author: Hiney, M.
Science Europe 2015
NRIN devotes a great deal of attention to the website’s content and would greatly appreciate your suggestions of documents or links you believe to belong on this website.
This selection is an incomplete convenience sample, and does not reflect NRIN’s vision or opinion. Including an item does not necessarily mean that we agree with the authors nor does it imply we think unmentioned items are of poorer quality.
Please report any suggestions, inaccuracies or nonfunctioning hyperlinks etc. that you discover. Thanks in advance!Contact